Skip to main content
Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0390
-0.0084 (-17.72%)
At close: May 23, 2025

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $5.11M in the twelve months ending March 31, 2025, up 54.70% year-over-year. In the year 2024, Petros Pharmaceuticals had annual revenue of $5.11M, down -12.20%.

Revenue
5.11M
Revenue Growth
+54.70%
P/S Ratio
0.02
Revenue / Employee
284.00K
Employees
18
Market Cap
83.49K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.11M-710.35K-12.20%
Dec 31, 20235.82M-169.67K-2.83%
Dec 31, 20225.99M-1.82M-23.29%
Dec 31, 20217.81M-1.75M-18.29%
Dec 31, 20209.56M-6.02M-38.63%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Elite Pharmaceuticals 70.00M
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
BioStem Technologies 332.45M
Revenue Rankings

Petros Pharmaceuticals News

More News